← SynDRA
DIPRAGLURANT
SynDRA canonical compound SYN0037068 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GRM5 |
|---|
| Mechanism of action | Glutamate receptor negative allosteric modulator |
|---|
All known targets
Mechanisms of action (all sources)
- Glutamate receptor negative allosteric modulator
- GRM5 MODULATOR
- Metabotropic glutamate receptor 5 modulator
- GRM5 NEGATIVE ALLOSTERIC MODULATOR
Cross-references
Synonyms
- ADX48621
- ADX-48621
- UNII-CV8JZR21A1
- CV8JZR21A1
- CHEMBL2346738
- 6-fluoro-2-[4-(2-pyridinyl)-3-butyn-1-yl]-Imidazo[1,2-a]pyridine
- Dipraglurant [INN]
- SCHEMBL103033
- GTPL6452
- C16H12FN3
- DTXSID90236230
- BCP23706
- BDBM50431705
- ZINC72266314
- 3590AH
- 6-Fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1,2-a)pyridine
- AKOS030526956
- SB16993
- DB12733
- CS-0690
- NCGC00351745-02
- HY-14859
- DB-076892
- FT-0705373
- J3.560.334D
- W-5761
- ADX 48621;ADX48621;ADX-48621
- dipraglurantum
- RefChem:134830
- DTXCID90158721
- 6-fluoro-2-(4-pyridin-2-ylbut-3-ynyl)imidazo[1,2-a]pyridine
- orb1707374
- SCHEMBL30079764
- EX-A10899
- MFCD18633187
- MS-23750
- NS00072954
- F84825
Look up DIPRAGLURANT in the interactive SynDRA portal →